The Cardiac Effects of COVID-19: Review of articles

Sana Niazi1, Feizollah Niazi2, Farideh Doroodgar3

  • 1Medical Students Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Insights

Severe acute respiratory syndrome coronavirus (SARS-CoV-2), the cause of COVID-19, significantly impacts cardiovascular health. Understanding COVID-19

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Virology

Background:

  • The COVID-19 pandemic, caused by SARS-CoV-2, has profoundly affected cardiovascular wellbeing.
  • Individuals with pre-existing heart conditions face elevated risks of severe illness and mortality.
  • COVID-19 presents with diverse cardiovascular manifestations, including acute coronary syndromes, myocardial injury, myocarditis, arrhythmias, heart failure, and thromboembolism.

Purpose of the Study:

  • To elucidate the direct and indirect cardiovascular effects of SARS-CoV-2 infection.
  • To examine the potential adverse cardiac effects of COVID-19 therapeutics.
  • To understand the role of the renin-angiotensin-aldosterone system (RAAS) in viral replication and its implications for patients on RAAS-modulating medications.
  • To highlight the necessity of detailed knowledge regarding COVID-19's cardiovascular symptoms and RAAS's prognostic significance for optimal patient management.

Main Methods:

  • Review of clinical data and existing literature on COVID-19 and cardiovascular complications.
  • Analysis of the interaction between SARS-CoV-2 and the renin-angiotensin-aldosterone system.
  • Evaluation of the impact of RAAS-modulating therapies in the context of COVID-19.

Main Results:

  • SARS-CoV-2 infection can precipitate a range of acute cardiovascular syndromes.
  • Pre-existing cardiovascular disease is a significant risk factor for poor COVID-19 outcomes.
  • The interplay between SARS-CoV-2 and the RAAS presents complex challenges for patient care and therapeutic strategies.

Conclusions:

  • Comprehensive understanding of COVID-19's cardiovascular manifestations is crucial for effective clinical management.
  • The role of the RAAS in COVID-19 pathogenesis and prognosis requires further investigation to guide therapeutic decisions.
  • Multidisciplinary approaches are essential to address the complex cardiovascular sequelae of COVID-19.

Related Concept Videos

Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...